DUBLIN--(BUSINESS WIRE)--The "Molecular Cytogenetics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies:
- Fluorescence In Situ Hybridization
- Array-based Technology.
The report profiles 27 companies including many key and niche players such as:
- Abbott Molecular (USA)
- Agilent Technologies, Inc. (USA)
- Applied Spectral Imaging (USA)
- Biological Industries (Israel)
- Bio-Rad Laboratories, Inc. (USA)
- Cytognomix, Inc. (Canada)
- CytoTest, Inc. (USA)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Illumina, Inc. (USA)
- Leica Biosystems Nussloch GmbH (Germany)
- Oxford Gene Technology (UK)
- PerkinElmer, Inc. (USA)
- SciGene Corporation (USA)
- Thermo Fisher Scientific, Inc. (USA)
Key Topics Covered:
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Definitions
Fluorescence In Situ Hybridization (FISH)
Select FISH Procedures in Use
3D-FISH
Cellular Compartment Analysis of Temporal Activity
Combined Binary Ratio-FISH
Cryo-FISH
Immuno-FISH
Quantum Dot-Conjugates-FISH
Array-based Technology
Array-based Comparative Genomic Hybridization (aCGH)
2. INDUSTRY OVERVIEW
Molecular Cytogenetics Technologies: An Introductory Prelude
Future Prospects Remain Favorable for Cytogenetics Technologies
Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment
Northbound Trajectory in Med Tech Sector Generates Parallel Opportunities
Developed Regions: Key Revenue Contributors
Fast Paced Growth Projected in Developing Regions
Prevailing Economic Scenario Favors Market Expansion
3. KEY MARKET TRENDS & GROWTH DRIVERS
Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth
Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies
Array-based Technologies: Largest & Fastest Growing Market Segment
Transition from FISH to Array Based Technologies: The Ongoing Trend
Array-based CGH to Emerge as First Line Test for Clinical Diagnosis of Chromosomal Anomalies
Molecular Cytogenetics Find Increasing Penetration in Clinical Pathological Testing
Enhanced AP LIS: A Must to Keep Pace with Advancing Molecular Cytogenetic Testing
Impact of Shifting Focus of Biopharmaceuticals from Research to Development on Microarray Technology
Despite Proliferation of Array-based Methods, FISH Technology Continues to Find Favor
Next-Gen Sequencing Seeks Role in Cytogenetics Processes
Molecular Cytogenetics Greatly Benefit Cancer Prognosis
Diverse Applications of FISH Technology in Oncology
Opportunity Indicator: Global Cancer Incidence on the Rise
Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth
Expanding Role of Molecular Cytogenetics in Personalized Medicine
Demographics Spell Growth Opportunities
4. TECHNOLOGY OVERVIEW
A Preface to Cytogenetics
Basic Terms and Definitions in Molecular Biology
DNA and RNA
RNA (Ribose nucleic acid)
Chromosomes
Gene
Genotype
Phenotype
Haplotype
Karyotyping
Karyotype
Nick
Probe
Reporter Molecule
Copy Number
Copy Number Variation
Analysis of Copy Numbers Variations
Chromosomal Abnormalities in Human Beings
An Overview of Select Chromosomal Anomalies
Insertions
Deletions
Duplication
Rearrangement
5. COMPETITIVE LANDSCAPE
American Companies Dominate the Cytogenetics Technologies Market
Competition from European Vendors Remains Firm
Vendors Emphasize Collaborations
Select Cytogenetics Technology Collaborations Announced in the Recent Past
M&A Activity
Select Recently Finalized M&A Deals in the Cytogenetics Technologies Marketplace
5.1 Focus on Select Global Players
5.2 Product Launches
SciGene Introduces CytoBrite PLUS Slide Incubation System
ASI Unveils Updated GenASIs Platform
5.3 Recent Industry Activity
OGT Leverages Sysmex's European Network to Sell Cytocell FISH Products
Roche Molecular Systems to Shut NimbleGen Facility
Sysmex to Acquire Oxford Gene Technology
GeneDx Joins Hands with UC Health for Molecular Testing Services
Empire Genomics Teams Up with KromaTiD for Oncology Diagnostics
CytoTest Expands Sales Team in Europe
Thermo Fisher Scientific Acquires Affymetrix
Agilent Inks Co-Marketing Agreement with Applied Spectral Imaging
Empire Genomics Expands Global Distribution Network
CytoTest and CapitalBio to Jointly Develop Advanced Molecular Diagnostic Solutions
6. GLOBAL MARKET PERSPECTIVE
By Technology
7. REGIONAL MARKET PERSPECTIVE
7.1 The United States
A. Market Analysis
The United States: Prime Market for Cytogenetics Technologies
aCGH Predominate the Technological Front in Molecular Cytogenetics
The Clinical Sector: A Potential Market Opportunity for Array-based Technologies
Revised ACMG Guidelines to Accelerate Use of aCGH Over FISH Technology
Established Role of FISH Technology in Cytogenetics Applications
FISH in Diagnosis of Bladder Carcinoma
FISH in Breast Cancer Diagnosis
Restraints for Oncology FISH Probes
IHC Tests Curtail FISH Demand
Ageing Population and Growing Incidence of Cancer & Lifestyle Diseases - Opportunity Indicators
Emphasis on Personalized Medicine & Companion Diagnostics Widens Scope
B. Market Analytics
7.2 Canada
Market Analysis
7.3 Japan
A. Market Analysis
Japan Offers Robust Opportunities
Demographics Favor Demand Expansion
B. Market Analytics
7.4 Europe
A. Market Analysis
A Mature yet Growing Market
Analysis by Region
Analysis by Technology
Cancer Statistics in Europe
B. Market Analytics
7.4.1 France
Market Analysis
7.4.2 Germany
Market Analysis
7.4.3 Italy
Market Analysis
7.4.4 The United Kingdom
Market Analysis
7.4.5 Spain
Market Analysis
7.4.6 Russia
Market Analysis
7.4.7 Rest of Europe
Market Analysis
7.5 Asia-Pacific
A. Market Analysis
Asia-Pacific Evolves as Fastest Growing Market
Analysis by Region
Analysis by Technology
Factors Driving Demand for Laboratory Technologies in Asia-Pacific: A Review
Growing Biotech Sector
Increased Access to Healthcare & Rising Healthcare Awareness
Proliferation of Medical Tourism
B. Market Analytics
7.5.1 China
A. Market Analysis
China - A Market Laden with Opportunities
FISH Technology in Clinical Diagnostics
B. Market Analytics
7.5.2 Rest of Asia-Pacific
A. Market Analysis
An Insight into the Indian Microarray Market
B. Market Analytics
7.6 Rest of World
Market Analysis
8. COMPANY PROFILES
Total Companies Profiled: 27 (including Divisions
Subsidiaries - 29)
- The United States (20)
- Canada (1)
-
Europe (6)
- Germany (2)
- The United Kingdom (1)
- Rest of Europe (3)
- Asia-Pacific (Excluding Japan) (1)
For more information about this report visit https://www.researchandmarkets.com/research/d2bwh9/molecular?w=4
